HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshifumi Hibi Selected Research

Ulcerative Colitis

10/2022Safety and efficacy of long-term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open.
3/2022Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial.
1/2022Efficacy of Biologic Drugs in Short-Duration Versus Long-Duration Inflammatory Bowel Disease: A Systematic Review and an Individual-Patient Data Meta-Analysis of Randomized Controlled Trials.
1/2022Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results.
1/2022Lack of Increased Risk of Lymphoma with Thiopurine Therapy Regardless of Dose and Duration of Treatment in Japanese Patients with Inflammatory Bowel Diseases.
1/2022Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis.
1/2022Lower effectiveness of intravenous steroid treatment for moderate-to-severe ulcerative colitis in hospitalised patients with older onset: a multicentre cohort study.
1/2022AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
1/2022Efficacy and Safety of Continued Treatment With Mirikizumab in a Phase 2 Trial of Patients With Ulcerative Colitis.
10/2021Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshifumi Hibi Research Topics

Disease

113Ulcerative Colitis
10/2022 - 01/2002
70Crohn Disease (Crohn's Disease)
06/2022 - 08/2002
41Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2022 - 09/2002
40Neoplasms (Cancer)
01/2022 - 07/2003
38Inflammation (Inflammations)
08/2021 - 12/2002
36Colitis
10/2020 - 02/2003
33Infections
03/2021 - 09/2004
20Hemorrhage
05/2022 - 12/2005
15Stomach Neoplasms (Stomach Cancer)
01/2014 - 02/2003
12Chronic Hepatitis C
01/2015 - 05/2005
10Ulcer
01/2020 - 07/2005
9Necrosis
05/2022 - 12/2008
9Non-alcoholic Fatty Liver Disease
01/2018 - 12/2005
9Dyspepsia (Indigestion)
02/2016 - 11/2005
9Liver Cirrhosis (Hepatic Cirrhosis)
07/2014 - 06/2007
8Carcinogenesis
12/2013 - 07/2003
8Fibrosis (Cirrhosis)
11/2013 - 09/2005
7Hepatocellular Carcinoma (Hepatoma)
09/2013 - 01/2005
6Colorectal Neoplasms (Colorectal Cancer)
04/2018 - 07/2003
6Hepatitis
01/2014 - 01/2008
6Pancreatic Neoplasms (Pancreatic Cancer)
02/2013 - 06/2009
6Fatty Liver
01/2013 - 11/2004
6Liver Diseases (Liver Disease)
12/2012 - 06/2007
6Gastritis
05/2010 - 09/2004
5Tuberculosis (Tuberculoses)
08/2021 - 01/2018
5Body Weight (Weight, Body)
01/2021 - 07/2005
5Polyps
04/2016 - 10/2010
5Neoplasm Metastasis (Metastasis)
12/2014 - 11/2004
5Ischemia
02/2012 - 01/2005
5Atrophy
12/2011 - 09/2004
4Pathologic Constriction (Stenosis)
06/2020 - 10/2007
4Disease Progression
04/2018 - 06/2008
4Stomach Ulcer (Gastric Ulcer)
02/2013 - 12/2004
4Lymphatic Metastasis
01/2013 - 02/2003
4Carcinoma (Carcinomatosis)
01/2013 - 11/2003

Drug/Important Bio-Agent (IBA)

29Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2021 - 06/2003
26Infliximab (Remicade)FDA Link
05/2022 - 12/2005
20Mesalamine (Mesalazine)FDA LinkGeneric
01/2022 - 08/2009
19Adalimumab (Humira)FDA Link
01/2022 - 03/2012
17SteroidsIBA
01/2022 - 01/2003
17CytokinesIBA
12/2013 - 12/2002
16Pharmaceutical PreparationsIBA
01/2022 - 11/2004
11Monoclonal AntibodiesIBA
08/2021 - 02/2003
11InterferonsIBA
01/2015 - 05/2005
10Biological ProductsIBA
01/2022 - 09/2002
10Proteins (Proteins, Gene)FDA Link
11/2015 - 11/2003
10GhrelinIBA
12/2012 - 09/2004
9Capsules (Microcapsules)IBA
04/2021 - 10/2007
9Therapeutic UsesIBA
04/2018 - 02/2003
8vedolizumabIBA
01/2022 - 01/2019
8DNA (Deoxyribonucleic Acid)IBA
11/2021 - 05/2005
8MicroRNAs (MicroRNA)IBA
12/2013 - 01/2009
8Proton Pump InhibitorsIBA
12/2013 - 01/2005
7Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 12/2015
7Biomarkers (Surrogate Marker)IBA
12/2019 - 08/2009
7AntigensIBA
01/2018 - 03/2004
7Ribavirin (Virazole)FDA LinkGeneric
01/2015 - 10/2006
7Messenger RNA (mRNA)IBA
07/2013 - 09/2007
7EnzymesIBA
01/2013 - 09/2005
7Interleukin-12 (IL 12)IBA
06/2012 - 12/2002
62-mercaptopurineIBA
01/2022 - 01/2015
6Interleukin-23 (Interleukin 23)IBA
01/2022 - 11/2005
6C-Reactive ProteinIBA
01/2022 - 02/2003
6Budesonide (Pulmicort)FDA LinkGeneric
01/2020 - 04/2013
6Dextran SulfateIBA
01/2014 - 08/2003
6Anti-Bacterial Agents (Antibiotics)IBA
12/2012 - 11/2004
6InterleukinsIBA
09/2011 - 06/2003
5Interleukin-10 (Interleukin 10)IBA
10/2016 - 03/2010
5Interleukin-6 (Interleukin 6)IBA
09/2015 - 04/2004
5Immunoglobulin G (IgG)IBA
12/2013 - 01/2007
5Cisplatin (Platino)FDA LinkGeneric
01/2013 - 11/2003
5Toll-Like Receptors (Toll-Like Receptor)IBA
12/2012 - 01/2006
5AcidsIBA
12/2011 - 01/2005
5Ethanol (Ethyl Alcohol)IBA
12/2009 - 12/2004
4tofacitinibIBA
10/2022 - 01/2018
4Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2022 - 01/2017
4Immunologic Factors (Immunomodulators)IBA
01/2022 - 02/2020
4Immunosuppressive Agents (Immunosuppressants)IBA
01/2021 - 01/2002
4TabletsIBA
07/2020 - 01/2017
4Azathioprine (Imuran)FDA LinkGeneric
09/2019 - 01/2003
4CholesterolIBA
10/2017 - 01/2012
4Prednisolone (Predate)FDA LinkGeneric
03/2015 - 06/2005
4Carbon Tetrachloride (Tetrachloromethane)IBA
07/2014 - 01/2012
4Transforming Growth Factors (Transforming Growth Factor)IBA
01/2014 - 03/2011
4NF-kappa B (NF-kB)IBA
02/2011 - 01/2003
4Interleukin-7 (Interleukin 7)IBA
09/2010 - 04/2005
4Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2009 - 09/2005
4AldehydesIBA
03/2007 - 07/2005
4AcetaldehydeIBA
03/2007 - 07/2005
4Interferon-betaIBA
09/2006 - 05/2005
3Janus Kinase InhibitorsIBA
10/2022 - 04/2018

Therapy/Procedure

94Therapeutics
03/2022 - 01/2002
13Drug Therapy (Chemotherapy)
01/2013 - 02/2003
11Blood Component Removal (Apheresis)
04/2020 - 05/2004
8Remission Induction
01/2022 - 09/2010
4Restorative Proctocolectomy
10/2020 - 10/2007
4Colectomy
07/2020 - 11/2010
4Liver Transplantation
03/2015 - 01/2009
4Ligation
07/2014 - 10/2010
3Blood Transfusion (Blood Transfusions)
05/2022 - 09/2007